Abstract

Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study

Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana

Issue: Mar/Apr 2023 - Volume 27, Number 2

Page(s): 108-112

Download in electronic PDF format for $75
  • Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 1
  • Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 2
  • Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 3
  • Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 4
  • Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 5

Abstract

A postmenopausal female patient was suffering from vulvovaginal symptoms such as dryness and irritation, which were affecting her relationship with her partner and her overall quality of life. The patient was instructed to apply an estriol 0.1% vaginal ointment (PCCA Ellage Anhydrous Vaginal) for a duration of three months. The safety and efficacy of the compounded treatment were evaluated using an online data collection form, which included the validated Vulvovaginal Symptom Questionnaire. Post-treatment results show that the vulvovaginal symptoms were no longer bothersome, and that the patient’s relationship was no longer affected. There were no reports of undesirable effects as a result of the compounded treatment. This case study reinforces the benefits and convenience of using topical hormone replacement therapy in postmenopausal women.

Related Keywords

  • vulvovaginal symptoms
  • vulvar irritation
  • vaginal dryness
  • postmenopausal women
  • menopause
  • estrogen deficiency
  • chronic vaginal atrophy
  • dyspareunia
  • painful intercourse
  • sexual function
  • quality of life
  • relationships
  • estriol 0.1% vaginal ointment
  • topical preparation
  • topical hormone replacement therapy
  • intravaginal administration
  • Vulvovaginal Symptom Questionnaire
  • drug safety
  • formulations

Related Categories

  • FORMULATIONS
  • HRT
  • MENTAL HEALTH
  • CASE REPORTS
  • DOSAGE FORMS/DRUG CARRIERS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2023
Pg. 108-112
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Jan/Feb 2004
Pg. 16-21
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Author(s): Cutter Christopher B
Nov/Dec 2010
Pg. 465-471
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Author(s): Bramwell Bethany L
Jul/Aug 2008
Pg. 295-304
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Mar/Apr 2004
Pg. 96-99
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2
Author(s): Cutter Christopher B
Nov/Dec 2018
Pg. 456-465
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Author(s): Riepl Mike
Sep/Oct 2003
Pg. 330-338
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Author(s): Gillson George R, Zava David T
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Author(s): Deleruyelle Laura J
Jan/Feb 2019
Pg. 77-81
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Author(s): Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Jan/Feb 2017
Pg. 6-16
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Author(s): Deleruyelle Laura J
Sep/Oct 1999
Pg. 357-359
Women's Health Book Reviews
Author(s): Reed-Kane Dana
Nov/Dec 2004
Pg. 427-435
The Salivary Hormone Profile in the Clinical Evaluation of Women
Author(s): Stephenson Kenna
Jul/Aug 2002
Pg. 255-256
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Author(s): Mason Dave
Jan/Feb 2014
Pg. 70-77
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Author(s): Ruiz Andres D, Daniels Kelly R
Nov/Dec 2009
Pg. 556
Gentian Violet Vaginal Suppositories
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 165-170
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Author(s): Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Sep/Oct 2008
Pg. 450
Estradiol 0.1% Vaginal Solution
Author(s): Allen Loyd V Jr